Canada Life’s OptiNose OPTN Stock Holding History

Canada Life’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-138	Closed	-$9K	–	2792
2020 Q1	$9K	Hold	138	–	–	﹤0.01%	2523
2019 Q4	$19K	Buy	+138	New	+$17.9K	﹤0.01%	2508

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Canada Life's OPTN Position: Q2 2020 in Review

Canada Life sold out of OptiNose (OPTN) in Q2 2020, closing a stake of 138 shares — an estimated $9K sold.

Canada Life first reported a position in OPTN in Q4 2019 and held it in 2 quarters. The position peaked at $19K in Q4 2019. 72 funds tracked by Wall St. Rank hold OPTN as of Q2 2020.

Canada Life reported no remaining OptiNose position as of Q2 2020 after selling out during the quarter.
Canada Life sold 138 OptiNose shares in Q2 2020, an estimated $9K.
Canada Life first reported a position in OptiNose in Q4 2019 and held it in 2 quarters.
Canada Life's OptiNose position peaked at $19K in Q4 2019.
72 funds tracked by Wall St. Rank held OptiNose as of Q2 2020.

Based on Canada Life's 13F filing for Q2 2020, filed 17 Aug 2020.